Philogen SpA
MIL:PHIL
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Philogen SpA
MIL:PHIL
|
IT |
|
D
|
Deutsche EuroShop AG
XMUN:DEQ
|
DE |
|
Posco Holdings Inc
KRX:005490
|
KR |
|
H
|
Heidelberg Pharma AG
XMUN:HPHA
|
DE |
|
G
|
Gladstone Commercial Corp
F:GLE
|
US |
|
Mediaalpha Inc
NYSE:MAX
|
US |
|
Agora Inc
NASDAQ:API
|
CN |
|
A
|
Avance Gas Holding Ltd
XMUN:A07
|
BM |
|
P
|
Purepoint Uranium Group Inc
F:P5X
|
CA |
Wall St Price Targets
PHIL Price Targets Summary
Philogen SpA
According to Wall Street analysts, the average 1-year price target for
PHIL is 28.22 EUR with a low forecast of 19.19 EUR and a high forecast of 35.7 EUR.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is PHIL's stock price target?
Price Target
28.22
EUR
According to Wall Street analysts, the average 1-year price target for
PHIL is 28.22 EUR with a low forecast of 19.19 EUR and a high forecast of 35.7 EUR.
What is the Revenue forecast for Philogen SpA?
Projected CAGR
-36%
Over the last 7 years, the compound annual growth rate for Revenue has been 56%. The projected CAGR for the next 3 years is -36%.
What is the Gross Profit forecast for Philogen SpA?
Projected CAGR
-60%
Over the last 7 years, the compound annual growth rate for Gross Profit has been 68%. The projected CAGR for the next 5 years is -60%.